PAX Labs, a vaporizer technology company partnered with several Canadian licensed producers (LPs), has elected to reduce its workforce by approximately 25 percent.

Most recently, PAX Labs formed a partnership with Zenabis Global (TSX:ZENA). It also has relationships with The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF), Aphria (NYSE:APHA,TSX:APHA), Aurora Cannabis (NYSE:ACB,TSX:ACB) and Organigram Holdings (NASDAQ:OGI,TSXV:OGI).


In a statement to the Investing News Network (INN), a PAX Labs spokesperson said the cuts were due to a recent “significant revenue miss” that affected the firm.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“In light of this fact, coupled with evolving business priorities and industry dynamics, we have made the difficult decision to part ways with 65 members of our team, or 25 percent of the organization, effective today,” the statement from PAX Labs explains.

The vape pen company did not indicate how this reduction in its workforce could affect its plans for the Canadian market and its partnerships with Canadian players.

First reported by Marijuana Business Daily, the downsize is linked to the state of the vape market due to the recent health crisis seen in the US linked to vape pens.

PAX Labs’ supply deals in the Canadian marijuana market came recently. Supreme Cannabis, Aphria and Aurora all signed on as brand partners for the company’s PAX Era pen and pod system in June.

“Together, we expect to deliver 7ACRES’ multi-award winning flower extracted into oils exclusively for use in North America’s best-selling premium vaporizer, the PAX Era,” Navdeep Dhaliwal, CEO of Supreme Cannabis, said in a partnership statement at the time.

Supreme Cannabis’ deal is related to the exclusive availability of products from its recreational brand 7ACRES with the PAX Era pen and pod product.

In a statement, PAX Labs, which is based in San Francisco, California, indicated that its LP partners would expand the experience of using PAX Era products.

“As the market grows, we will continue to bring on more brand partners, offering our consumers a selection of products on the PAX Era platform,” said Tim Pellerin, Canadian general manager with PAX Labs, at the time the four deals were announced.

Zenabis linked up with PAX Labs in September. Under the agreement, the Canadian producer will supply cannabis extracts for the same vaporizer device.

“We are pleased to partner with PAX … and to join the other four Canadian LP’s in the launch of PAX Era Pods,” Andrew Grieve, CEO of Zenabis, previously said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, in connection with the previously announced share consolidation on a thirty (30) for one (1) basis (the “Consolidation”), the Company will be changing its name to West Island Brands Inc. (the “Name Change”).

The common shares are scheduled to begin trading on a post-consolidation basis at market open on October 20, 2021 under the stock symbol “WIB”. The new CUSIP number will be 953400108 and the new ISIN number will be CA9534001081. Following the Consolidation, the Company will have approximately 10,712,484 common shares issued and outstanding.

Keep reading... Show less

In the cannabis space this week, a popular beverage maker hired a new executive in hopes of pursuing opportunities in the cannabis drink industry.

Meanwhile, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced a fresh acquisition agreement for a partner designed to boost its presence in a potentially available US adult-use cannabis market.

Keep reading... Show less

Via InvestorWireIBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be collaborating with Microdose Psychedelic Insights for the Psych e delic Capital: October 2021 Conference which is set to be held in an entirely virtual format on Oct. 28, 2021.

The Psychedelic Capital: October Conference is set to be a virtual event, covering the most innovative and cutting-edge companies, latest IPOs, newest opportunities and deepest insights into the global psychedelic industry. From exploring ongoing governmental policy shifts to commercial product breakthroughs, the conference will serve to educate attendees on the potential uses and benefits attached to psychedelics in today’s environment.

Keep reading... Show less

 Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”) today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers License application.

Record September Shipments
Adastra shipped 68,272 consumer-packaged units and 20,000g of bulk extract in September compared to 41,571 units in September 2020 , a 64% increase year over year.

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, pursuant to a director’s resolution, the Company will be consolidating its issued and outstanding share capital on the basis of every thirty (30) old Common Shares being consolidated into one (1) new Common Share (the “Share Consolidation”). Any fractional shares remaining after giving effect to the Share Consolidation will be cancelled.

As a result, the outstanding Common Shares of the Company will be reduced to approximately 10,712,484. The Company has no other securities outstanding.

Keep reading... Show less